In contrast, in immunoresponsive tumors such as osteosarcoma, high SQOR expression enhances systemic antioxidant homeostasis and anti-tumor immune activity, thus inhibiting tumor progression (suppressing tumor growth) (Wang Y. et al., 2024). Here, SQOR is linked to osteosarcoma.